Cargando…
Antimicrobial pharmacodynamics of vancomycin and disulfiram (Antabuse®) in Staphylococcus aureus
INTRODUCTION: Intravenous vancomycin (VAN) is the primary treatment for systemic infections due to methicillin-resistant Staphylococcus aureus (MRSA). Pharmacokinetic/pharmacodynamic target (PK/PD) indices for VAN therapies are more difficult to achieve for MRSA isolates with a minimum inhibitory co...
Autores principales: | Chavva, Hasitha, Meka, Yogesh, Long, Timothy E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854118/ https://www.ncbi.nlm.nih.gov/pubmed/36687633 http://dx.doi.org/10.3389/fmicb.2022.1092257 |
Ejemplares similares
-
Overview of Antabuse(®) (Disulfiram) in Radiation and Cancer Biology
por: Jia, Yaqi, et al.
Publicado: (2021) -
Disulfiram (Antabuse) Activates ROS-Dependent ER Stress and Apoptosis in Oral Cavity Squamous Cell Carcinoma
por: Shah O’Brien, Priyanka, et al.
Publicado: (2019) -
Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus
por: Hu, Qiwen, et al.
Publicado: (2016) -
Resistance Evolution Against Antimicrobial Peptides in Staphylococcus aureus Alters Pharmacodynamics Beyond the MIC
por: El Shazely, Baydaa, et al.
Publicado: (2020) -
Reconstruction of the Vancomycin-Susceptible Staphylococcus aureus Phenotype From a Vancomycin-Intermediate S. aureus XN108
por: Peng, Huagang, et al.
Publicado: (2018)